Cetuximab påvirker også cytotoksiske immun- effektorceller mod tumorceller med EGFR (antibody dependent cell- mediated cytotoxicity, ADCC).
Cetuximab also targets cytotoxic immune effector cells towards EGFR-expressing tumour cells (antibody dependent cell-mediated cytotoxicity, ADCC).